Hims Stock

forhims.comHealthcare / Other HealthcareFounded: 2017Funding to Date: $197MM

Hims and hers is a provider of FDA-approved, medical-grade health and wellness products.

Register for Details

For more details on financing and valuation for Hims, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Hims.

Register Today

Team

Management Team

Pat Carroll
Chief Medical Officer
Spencer Lee
Chief Financial Officer
Jack Abraham
Co-Founder & Executive Chairman
Andrew Dudum
Founder & Chief Executive Officer
Joe Spector
Senior Vice President of Partnerships and Operations

Board Members

Thomas Rodgers
Jack Abraham

Other companies like Hims in the Other Healthcare sector

Sector
Last Round Est. Valuation
$165MM
Sector
Last Round Est. Valuation
$368.08MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$125MM
Sector
Last Round Est. Valuation
$140MM
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$173.59MM
Sector
Last Round Est. Valuation
$300.91MM

News Highlights

$380 billion juggernaut UnitedHealth is getting into one of the hottest parts of healthcare, and that should be a warning for upstarts like Hims and Ro
UnitedHealth's revamped Optum Store brings new competition to the direct-to-consumer healthcare market.
The CEO of telemedicine Hims is 'optimistic' about Biden's healthcare plan: 'There's a great sense of relief.'
Hims just went public in a $1.6 billion SPAC deal and the CEO tells Insider he's 'optimistic' about Biden's healthcare plan.
Hims CEO took a trip to China before COVID hit and still sees Asia as a 'massive market opportunity.'
As the company goes public in a $1.6 billion SPAC deal, the CEO of Hims reveals how he's looking at the Chinese market.
Updated on: Sep 27, 2023